Descriptor English: | Polymyositis | ||||||
Descriptor Spanish: |
Polimiositis
| ||||||
Descriptor Portuguese: | Polimiosite | ||||||
Descriptor French: | Polymyosite | ||||||
Entry term(s): |
Idiopathic Polymyositides Idiopathic Polymyositis Multiple Myositis Myositides, Multiple Myositis, Multiple Ossificans, Polymyositis Polymyositides Polymyositides, Idiopathic Polymyositis Ossificans Polymyositis, Idiopathic |
||||||
Tree number(s): |
C05.651.594.819 C10.668.491.562.575 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017285 | ||||||
Scope note: | Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9) |
||||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
Previous Indexing: |
Myositis (1966-1992) |
||||||
Public MeSH Note: | 93 |
||||||
History Note: | 93 |
||||||
DeCS ID: | 30612 | ||||||
Unique ID: | D017285 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1993/01/01 | ||||||
Date of Entry: | 1992/05/22 | ||||||
Revision Date: | 2013/07/09 |
|
Polymyositis
- Preferred
Polymyositis, Idiopathic
- Narrower
Polymyositis Ossificans
- Narrower
Concept UI |
M0026239 |
Scope note | Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9) |
Preferred term | Polymyositis |
Entry term(s) |
Multiple Myositis Myositides, Multiple Myositis, Multiple Polymyositides |
Concept UI |
M0337305 |
Preferred term | Polymyositis, Idiopathic |
Entry term(s) |
Idiopathic Polymyositides Idiopathic Polymyositis Polymyositides, Idiopathic |
Concept UI |
M0337304 |
Preferred term | Polymyositis Ossificans |
Entry term(s) |
Ossificans, Polymyositis |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey